Evidence map›Paper›PMID 30890583›Full record

ArticleDisease models & mechanisms2019

Enhancing regeneration after acute kidney injury by promoting cellular dedifferentiation in zebrafish.

Lauren Brilli Skvarca, Hwa In Han, Eugenel B Espiritu, Maria A Missinato, Elizabeth R Rochon, Michael D McDaniels, Abha S Bais, Beth L Roman, Joshua S Waxman, Simon C Watkins and 3 more

Open access · goldAbstract read
In one paragraph

Article in Disease models & mechanisms, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Stem cells in organogenesis and regeneration.Stem cell research & therapy · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. SARS-CoV-2 viral protein ORF3A injures renal tubules by interacting with TRIM59 to induce STAT3 activation.Molecular therapy : the journal of the American Society of Gene Therapy · 2023
    Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Lauren Brilli SkvarcaDepartment of Developmental Biology, University of Pittsburgh, Pittsburgh, PA 15261, USA.
Hwa In HanDepartment of Developmental Biology, University of Pittsburgh, Pittsburgh, PA 15261, USA.
Eugenel B EspirituDepartment of Developmental Biology, University of Pittsburgh, Pittsburgh, PA 15261, USA.
Maria A MissinatoDepartment of Developmental Biology, University of Pittsburgh, Pittsburgh, PA 15261, USA.
Elizabeth R RochonPittsburgh Heart, Lung, and Blood Vascular Medicine Institute, Department of Medicine, University of Pittsburgh, Pittsburgh, PA 15261, USA.
Michael D McDanielsDepartment of Developmental Biology, University of Pittsburgh, Pittsburgh, PA 15261, USA.
Abha S BaisDepartment of Developmental Biology, University of Pittsburgh, Pittsburgh, PA 15261, USA.ORCID 0000-0001-5910-1306
Beth L RomanHuman Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA 15261, USA.
Joshua S WaxmanHeart Institute, Molecular Cardiovascular Biology Division, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.ORCID 0000-0002-8132-487X
Simon C WatkinsDepartment of Cell Biology and Center for Biological Imaging, University of Pittsburgh, Pittsburgh, PA 15261, USA.
Alan J DavidsonMolecular Medicine and Pathology, University of Auckland, Auckland, New Zealand.
Michael TsangDepartment of Developmental Biology, University of Pittsburgh, Pittsburgh, PA 15261, USA.
Neil A HukriedeDepartment of Developmental Biology, University of Pittsburgh, Pittsburgh, PA 15261, USA hukriede@pitt.edu.ORCID 0000-0002-9655-9030
University of Pittsburgh · USCincinnati Children's Hospital Medical Center · USUniversity of Auckland · NZ

Funding

Single Nephron and MetabolomicsP30DK079307 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI APODACA, GERARD L · 2008 to 2022
$13.4M
Regulation of Renal Progenitor Cells in Regenerating KidneysR01DK069403 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI HUKRIEDE, NEIL A · 2006 to 2020
$4.8M
Molecular Mechanisms of Atrial Development and RegenerationR01HL137766 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI Joshua Waxman · 2017 to 2026
$3.9M
Renal and Epithelial Biology Training ProgramT32DK061296 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KLEYMAN, THOMAS R · 2002 to 2022
$3.1M
Utilizing Small Molecule Screens to Delineate Embryonic Signaling MechanismsR01HD053287 · NICHD · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI HUKRIEDE, NEIL A, TSANG, MICHAEL WAIKOK · 2007 to 2016
$3.1M
Coup-tf dependent mechanisms of ventricular and hemangioblast specificationR01HL112893 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI WAXMAN, JOSHUA · 2013 to 2017
$1.7M
Retinoic acid-dependent epigenetic and transcriptional mechanisms controlling heart developmentR01HL141186 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI WAXMAN, JOSHUA · 2018 to 2021
$1.6M
High content in vivo screening for acute kidney injury ameliorating drugsR01DK112652 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI HUKRIEDE, NEIL A, VOGT, ANDREAS · 2017 to 2019
$1.1M
Elucidating the Mechanisms of Kidney Regeneration and Therapeutic AugmentationF30DK101143 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SKVARCA, LAUREN BRILLI · 2013 to 2016
$185k
NHLBI NIH HHS R01 HL112893NHLBI NIH HHS R01 HL137766NHLBI NIH HHS R01 HL141186NICHD NIH HHS R01 HD053287NIDDK NIH HHS F30 DK101143NIDDK NIH HHS P30 DK079307NIDDK NIH HHS R01 DK069403NIDDK NIH HHS R01 DK112652NIDDK NIH HHS T32 DK061296
6 · The paper itself

Abstract

Acute kidney injury (AKI) is a serious disorder for which there are limited treatment options. Following injury, native nephrons display limited regenerative capabilities, relying on the dedifferentiation and proliferation of renal tubular epithelial cells (RTECs) that survive the insult. Previously, we identified 4-(phenylthio)butanoic acid (PTBA), a histone deacetylase inhibitor (HDI), as an enhancer of renal recovery, and showed that PTBA treatment increased RTEC proliferation and reduced renal fibrosis. Here, we investigated the regenerative mechanisms of PTBA in zebrafish models of larval renal injury and adult cardiac injury. With respect to renal injury, we showed that delivery of PTBA using an esterified prodrug (UPHD25) increases the reactivation of the renal progenitor gene

Indexed as

Cell DedifferentiationRegenerationAcute Kidney InjuryAnimalsAnimals, Genetically ModifiedButyratesCell ProliferationEpithelial CellsImmune SystemKidney TubulesMacrophagesNeutrophilsPAX2 Transcription FactorProdrugsSignal TransductionSulfides4-(phenylthio)butanoic acidButyratespax2a protein, zebrafishPAX2 Transcription FactorProdrugsSulfidesTretinoinZebrafish ProteinsAcute kidney injuryCardiovascularHDAC inhibitorMacrophagesRenal proximal tubule cellTherapeutic

Identifiers

PMID30890583
PMCPMC6505474
OpenAlexW2949860157

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.